Search
Search
This workshop will highlight the use of the Oncomine™ TCR Pan-Clonality Assay for evaluating immune repertoires in T-cell lymphoma samples, with applications in clonality assessment and detection of measurable residual disease (MRD). Discussions will emphasize how these approaches align with current testing frameworks and expand the utility of NGS in hematologic research.
Speaker:
Mohamed H. Maher, Ph.D., Pharm.D.
Research Scientist
Genomic Test Development Laboratory (GTDL)
Translational Molecular Pathology
MD Anderson, The University of Texas